書籍詳細

I. 止血と検査

P.11 掲載の参考文献

• 1) 福武勝博, 山中學 編:血液凝固-止血と血栓. 東京:宇宙堂八木書店, 1982

• 2) 福武勝博, 緇莊和子:血液凝固の生化学. メディコピア 14:22-38, 1985

• 3) Mosesson MW and Doolittle RF:Molecular Biology of Fibrinogen and Fibrin. Ann NY Acad Sci, 1983. 408

• 4) Hada M, et al:Covalent crosslinking of von Willebrand factor to fibrin. Blood 68:95-101, 1986
  pubmed

• 5) 福武勝博, 福武勝幸:血液凝固における内因系と外因系の交流. 神奈川血液研究会誌 3:33-47, 1983

P.22 掲載の参考文献

• 1) 藤巻道男, 他編:実践止血凝固学-血小板・凝固・線溶検査法-. 医学書院, 1980

• 2) 青木延雄, 他編:出血の検査. 金原出版, 1980

• 3) 藤巻道男:出血性素因の検査. 標準臨床検査医学 (山中學, 他編), 医学書院, 1987

• 4) 藤巻道男, 他編:血液疾患, 症例・解説・検査, 2. 血液凝固編, 医学書院, 1984

P.30 掲載の参考文献

• 1) 鈴木弘文:自動凝固測定器. 臨床検査 (臨時増刊), 24:1436-1441, 1980

• 2) Fareed J, et al:Diagnostic efficacy of newer synthetic substrates method for assessing coagulation variables:A critical overview. Clin Chem 29:225, 1983
  pubmed

P.37 掲載の参考文献

• 1) 高宮脩:凝固・線溶検査試薬とその調製法. Medical Technology 13:786, 1985

• 2) 橋本仙一郎:血液凝固-止血と血栓, 下 (福武勝博, 山中學 編), 東京:宇宙堂八木書店, 1983. p223

II. 一般スクリーニング検査

P.45 掲載の参考文献

• 1) Duke WW:The relation of blood platelets to hemorrhagic disease:description of a method for determining the bleeding time and coagulation time and report of the three cases of hemorrhagic disease relieved by ransfusion. JAMA, 55:1185, 1910

• 2) Ivy AC, et al:The standardization of certain factors in the cutaneous "venostasis" bleeding time technique. J Lab Clin Med 26:1812, 1941

• 3) Mielke CH, et al:The standardized normal Ivy bleeding time and its prolongation by aspirin. Blood 34:204, 1969
  pubmed

• 4) Didisheim P, et al:Factors affecting hemostatic plug formation in an extracorporeal model. Ann NY Acad Sci 201:307, 1972

• 5) Blakely J, et al:An in vitro measurement of bleeding time. J Lab Clin Med 89:1306, 1977

• 6) Harker LA, et al:The bleeding time as a screening test for evaluation of platelet function. N Engl J Med 287:155, 1972
  pubmed

• 7) Rumpel T:Hautblutungen bei scarlach. Muncher Med Wchnschr 56:1404-1410, 1909

• 8) Stefanini M and Dameshek W:The Hemorrhagic Disorders. 2nd ed., New York, London:Grune and Stratton, 1962. p468-469

• 9) 日野志郎:臨床検査講座, 15. 血液学. 医歯薬出版株式会社, 1984. p226

• 10) 加藤勝治:血液学研究法. 東京:南山堂, 1948. p166

P.49 掲載の参考文献

• 1) 日野志郎:臨床検査講座, 15. 血液学, 第4版. 医歯薬出版. 1984. p238-241

• 2) Macfarlane RG:A simple method for measuring clot retraction. Lancet i:1199-1201, 1939

P.53 掲載の参考文献

• 1) 寺田秀夫, 他:血液検査マニュアル. 講談社

• 2) 福武勝博, 他:検査室診断の実際. 金原出版

III. 血小板の検査

P.64 掲載の参考文献

• 1) Solum NO, et al:Absence of the 145,000 molecular weight, soluble platelet membrane glycoprotein-lack of platelet agglutination. Thrombos Haemostas 42:1626, 1979

• 2) Kloczewiak M, et al:Platelet receptor recognition site on human fibrinogen. Synthesis and structure-function relationship of peptides corresponding to the carboxyl-terminal segment of the gamma-chain. Biochemistry 23:1767-1774, 1984

• 3) Bennett JS and Vilaire G:Exposure of platelet fibringen receptors by ADP and epinephrine. J Clin Invest 71:1393-1401, 1979

• 4) Kunicki T, et al:The formation of Ca-dependent complexes of platelet membrane GP IIb and IIIa in solution as determined by CIE. Blood 58:268-278, 1981

• 5) Peerschke EI, et al:Decreased association of calcium with platelet unable to aggregate due to thrombasthenia or prolonged calcium deprivation. Br J Haematol 46:247-256, 1980
  pubmed

• 6) Roth GJ and Majerus PW:The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein. J Clin Invest 56:624-632, 1975

• 7) Zaham J and Marder VJ:Acquired storage pool disease of platelet associated with circulating antiplatelet antibody. Am J Med 56:883, 1974
  pubmed

P.65 掲載の参考文献

• 1) 服部晃, 他:血小板, 巨核球の形態. Medical Technology 13:655-660, 1985

• 2) 安藤泰彦:血小板の多能性. Medicina 20:1650-1651, 1983

• 3) 服部晃, 他:血小板の粘着・凝集. Mebio 13 (No. 4), 1986

• 4) 寺田秀夫:止血凝固異常の臨床. 1, 医学書院, 1981. p26-27

• 5) 服部晃:血小板の形態と機能. 血液凝固-止血と血栓・上 (福武勝博, 山中學 編), 東京:宇宙堂八木書店, 1982. p235

P.67 掲載の参考文献

• 1) 寺田秀夫, 他:血小板容積. Medical Technology 13:684-686, 1985

• 2) 寺田秀夫:出血, 凝固異常の臨床. 医学書院, 1, 1981. p26-29

• 3) 服部晃:血小板の形態と機能. 血液凝固-止血と血栓 下 (福武勝博, 山中學 編), 東京:宇宙堂八木書店, 1982. p235-24968

P.68 掲載の参考文献

• 1) 寺田秀夫:出血, 凝固異常の臨床. 1, 医学書院, 1981. p29-30

P.69 掲載の参考文献

• 1) 藤巻道男, 他:実践止血凝固学, 1. 医歯薬出版, 1980. p39-40

P.71 掲載の参考文献

• 1) 藤巻道男, 他:実践止血凝固学, 1. 医歯薬出版, 1980. p40-42

P.74 掲載の参考文献

• 1) 安永幸二郎:血小板粘着能検査-ガラスビーズ法. 臨床検査 20:135-140, 1976

• 2) Hellem AJ:Platelet adhesiveness in von Willebrand's disease-a study with a new modification of the glass bead filter method, Scand J Haematol 7:347-382, 1970

P.78 掲載の参考文献

• 1) Born GVR:Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194:927, 1962

P.81 掲載の参考文献

• 1) Biggs R and Douglas AS:J Clin Path 6:23-29, 1953
  pubmed

• 2) Hardisty RH and Hutton RA:Brit J Heaematol 11:258-268, 1965

• 3) Spaet TH and Cintron J:Brit J Haematol 11:269-275, 1965

P.84 掲載の参考文献

• 1) 林 悟, 他:Micro ELISA による血小板表面 IgG 量の測定. 臨床病理 32:1253-1257, 1984
  Medical*Online

P.86 掲載の参考文献

• 1) 倉田義之, 他:抗血小板抗体の検査. Medical Technology 13:693-698, 1985.

P.88 掲載の参考文献

• 1) Terasaki PI, et al:Microdroplet testing for HLA-A,-B,-C and-D Antigens. Am J Clin Path 69:103-120, 1978

P.97 掲載の参考文献

• 1) The Panel on Diagnostic Application of Radioisotopes in Hematology, International Committee for Standardisation in Hematology:Recommended Methods for Radioisotope Platelet Survival Studies. Blood 50:1137, 1977

• 2) 油井徳雄, 室井秀一:血小板寿命の測定法. 臨床病理特集第 62号:32-45, 1985

• 3) 塚田理康, 斉藤京子:血小板寿命検査. 臨床検査 22:944-950, 1978

P.99 掲載の参考文献

• 1) 福武勝博, 編集:検査室診断の実際. 金原出版, 1973

P.103 掲載の参考文献

• 1) Yankee RA, et al:Platelet transfusion therapy. The selection of compatible platelet donors for refractory patients by lymphocyte HL-A typing. N Engl J Med 281:1208-1212, 1969
  pubmed

• 2) Yankee RA, et al:Selection of unrelated compatible platelet donors by lymphocyte HL-A matching. N Engl J Med 288:760-764, 1973
  pubmed

• 3) 荒木千枝子, 十字猛夫:抗白血球抗体検査法. 日本臨牀 42 (春季臨時増刊号):1499-1504, 1984

P.105 掲載の参考文献

• 1) Rains EW and Ross R:Purification of human platelet-drived growth factor. Meth Enzymol 109:749-773, 1985

• 2) Ross R and Glomset JA:The pathogellesis of atherosclerosis. N Engl J Med 295:369-377, 420-425, 1976

• 3) Oawes J et al:A radioimmuno assay for thrombospondin, used in a comparative study of thombospondin, B-thromboglobulin and platelet factor 4. Thromb Res 29:569-581, 1983

IV. 凝固検査

P.111 掲載の参考文献

• 1) 藤巻道男, 池松正次郎:血液凝固因子の系統的測定. 綜合臨牀 32:447, 1983

• 2) 山村雄一, 浅田敏雄, 編:血液タンパクの機能と構造. Biomedical Siences 5:91-130, 1984

P.118 掲載の参考文献

• 1) Proctor RR and Rapaport SI:The partial thromboplastin time with kaolin. Am J Clin Path 36:212-219, 1961
  pubmed

• 2) Langdell RD, et al:Effect f antihemophilic factor on one-stage clotting tests. J Lab Clin Med 41:637-647, 1953

• 3) 松岡松三, 品田章二:血液凝固, F:凝固亢進状態. 日本血液学全書 13, 丸善, 1979. p486-490

• 4) Kingdon HS, et al:Potentially thrombogenic materials in factor IX concentrates. Thromb Diath Haemorrh (Stuttg) 33:617-631, 1975

P.121 掲載の参考文献

• 1) Quick AJ, et al:A study of the coagulation defect in hemophilia and in jaundice. Am J Med Sci 190:501-511, 1935

• 2) Quick AJ:The prothrombin in hemophilia and in obstructive jaundice. J Biol Chem 109:501-511, 1935

P.123 掲載の参考文献

• 1) 藤巻道男, 他:実践止血凝固学-血小板 血液凝固 線溶検査法, 医歯薬出版, 1980

P.125 掲載の参考文献

• 1) 福武勝幸:凝固検査の順序. 臨床検査 25:228, 1981

P.127 掲載の参考文献

• 1) Owren PA and Standli OK:Normotest. Farmakotherapi 25:14, 1969

P.128 掲載の参考文献

• 1) 羽田雅夫, 他:血液と脈管, 5:586-589, 1984

• 2) 池松正次郎:先天性XIII因子欠乏症, 血液疾患症例 解説 検査(2) (藤巻道男, 他編), 医学書院, 1984. p 69 84

• 3) 寺田秀夫. 他:血液検査マニュァル. 講談社

P.137 掲載の参考文献

• 1) Glauss A:Gerinnungs physiologische Schneiomethode Zur Bestimmung des Fibrinogens. Acta Heamat 17:237, 1957

• 2) Quick AJ:Hemorrhagic Diseases and Thrombosis (2nd ed.), Philadelphia:Lea & Febiger, 1966. p 410

• 3) Parfentijev IA, et al:The determination of plasma fibrinogen bv turbidity ammonium sulfate. Arch Biochem 46:470, 1953

• 4) 片岡茂幸, 他:TG-Meterによる血漿フィブリノゲンの測定法. 臨床病理 23:466, 1975

• 5) Mancini C, et al:Immunochemical quantitation of antigens by single radial immunodiffusion. J Immunochem 2:235, 1965

• 6) 中村克己, 他:Laser nephelometry による凝固 線溶因子の検索. 臨床病理 29:655, 1981

P.148 掲載の参考文献

• 1) Ratnoff OD and Davie EW:The purification of activated Hageman factor (activated factor XII). Bichemistry 1:967-975, 1962

• 2) Rapaport SI, et al:Relation between levels of plasma thromboplastin component and prothrombin time by the P & P and quick method in patients receiving warfarin. New Engl J Med 267:125-130, 1962

• 3) Hardisty RM, et al:A one-stage factor VIII (antihemophilic globulin) assay and its use on venous and capillary plasma. Thromb Diath haemorrh 7:215-229, 1962
  pubmed

• 4) Tankersley DL, et al:Activation of factor XIII by dextran sulfate:The basis for an assay of factor XIII. Blood 62:448-456, 1983

• 5) Scott CF, et al:Amidolytic assay of human factor XI in plasma:Comparison with a coagulant assay and a new rapid radioimmunoassay. Blood 63:42-56, 1984

• 6) Rosen S, et al:A new chromogenic assay for determination of human factor VIII:Cactivity. Standardization of coagulation assays:An overview (Triplett DA, ed). North Skokie, Illinois:College of American Pathologist, 1982

• 7) Laurell CB:Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Ann Biochem 15:45:v 52, 1966

P.156 掲載の参考文献

• 1) Laurell CB:Electro immunoassay. Scand J Clin Lab Invest 29 (Suppl 124):21-37, 1972

• 2) 福井 弘:生物物理化学 28:17-23, 1984

• 3) Ruggeri ZM and Zimmerman TS:Variant von Willebrand's disease. Characterization of two subtype by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets. J Clin Invest 65:1318-1325, 1980
  pubmed

P.167 掲載の参考文献

• 1) Hathaway WE, et al:Evidence for a new plasma thromboplastin factor I case report, coagulation studies and physicochemical properties. Blood 26:521, 1965
  pubmed

• 2) Michael P, et al:Simple chromogenic peptide substrate assay for determining prekallikrein, kallikrein inhibition and kallikrein"like"activity in human plasma. Thrombosis Res 25:293, 1982

• 3) Laurell CB:Electroimmunoassay. Scand J Clin Lab Invest 29 (Suppl 124):21-37, 1972

• 4) Saito H, et al:Fitzgerald factor (high molecular weight kininogen) clotting activity in human plasma in health and disease, and in various animal plasmas. Blood 48:941, 1976
  pubmed

• 5) Mancini G, et al:Immunochemical quantitation of antigens by single radial diffusion. Immunochem 2:235, 1965

P.179 掲載の参考文献

• 1) Owren, PA:A quantitative one-stage method for the assay of prothrombin. Scand J Clin Lab Invest l:81-83, 1949

• 2) Sirridge, MS:Laboratory Evaluation of Haematology. Philadelphia:Lea & Febiger, 1974. p 145-148

• 3) Francis JL:A new chromogenic assay for the specific determination of prothrombin. J Clin Pathol 32:651-654, 1979
  pubmed

• 4) Egberg N and Heedman PA:Simplified performance of amidolytic factor X assay. Thromb Res 25:437, 1982
  pubmed

• 5) Laurell, CB:Antigen antibody crossed electrophoresis. Analyt Biochem 10:358, 1979

• 6) Meguro T and Yamada K:Simple and rapid test for PIVKA-II in plasma. Thromb Res 25:109-114, 1982

P.188 掲載の参考文献

• 1) 風間睦美:血漿凝固因子の定量的検査. 第XIII因子. 血液凝固-止血と血栓 下 (福武勝博, 山中 學編), 東京:宇宙堂八木書店, 1983. p394-410

• 2) Nishida Y, et al:A new rapid and simple assay for Factor XIII activity using dansylcadaverine incorporation and gelfiltration. Thromb Res 36:123-131, 1984

• 3) Lorand L, et al:Human factor XIII:Fibrin-stabilizing factor. Prog Hemost Thromb 5:245-290, 1980
  pubmed

V. 線溶検査

P.205 掲載の参考文献

• 1) Allington MJ:Detection of fibrin (ogen) degradation products by a latex clumping method. Scand J Haemat 13:115-119, 1971

• 2) 緇莊和子, 他:モノクローナル抗体を用いたラテックス凝集法による安定化フィブリン分解産物の検出について. 臨床病理33:1435-1439, 1985

• 3) Sawai M, et al:Method and apparatus for the measurement of antigens and antibodies. US pat No. 4 (118):192, 1978

• 4) 石本盛治:半導体レーザー光線を使用した凝固測定装置LC 101を用いたFDP測定法. 最新検査 3:53-57, 1985

• 5) Matsumoto T, et al:Monoclonal antibodies to fibrinogen-fibrin degradation products which contain D-domain. Thromb Res 38:297-302, 1985
  pubmed

• 6) Rylatt DB, et al:An immunoassay for human D-dimer using monoclonal antibodies. Thromb Res 31:767-778, 1983

• 7) 緇莊和子:安定化フィブリン分解産物 DDIE complex の測定法の開発と線溶過程における抗原性の変化について. 東京医科大学雑誌44:860N871, 1986

P.218 掲載の参考文献

• 1) Mancini G, et al:Immunochemical quantitation of antigens by single radial immunodiffusion. Internat J Immunochem 2:235-254, 1965

• 2) Laurell CB:Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 15:42-52, 1966

• 3) Hedner V and Nilson ME:Determination of plasminogen in human by a casein method. Thromb Diath Haemorrh 14:545-561, 1965

• 4) 松田保:線溶検査. 実践止血凝固学 (藤巻道男, 他編), 東京:医歯薬出版, 1980. p207-215

• 5) 高宮脩:凝固 線溶検査試薬とその調製法. Medical Technology 13 (臨時増刊):786-798, 1985

• 6) 風間睦美, 他:血液凝固 線溶検査. 日本臨牀 43 (秋季臨時増刊号):611-613, 1985

• 7) Aoki N, et al:Abnormal plasminogen. J Clin Invest 61:1186-1195, 1978
  pubmed

• 8) 坂田洋一:線溶に関する検査. Medical Technology 13 (臨時増刊):731-736, 1985

• 9) Aoki N, et al:Differences of frequency distributions of plasminogen pheno-types between Japanese and American populations:New methods for the detection of plasminogen variants. Biochem Genet 22:871-881, 1984

• 10) Aoki N, et al:The behavior of a2-plasmin inhibitor in fibrinolytic state. J Clin Invest 60:361-369, 1977

• 11) Sakata Y:Metabolism of fibrinolytic system, Especially that of a2-plasmin inhibitor in a2-plasmin inhibitor deficient patient. Acta Haemat Jap 44:262-268, 1981

• 12) Thorsen S, et al:Differences in the binding to fibrin of urokinase and tissue plasminogen activator. Thromb Diath Haemorrh 28:65-74, 1972
  pubmed

• 13) Bachmann F, et al:Tissue plasminogen activator:Chemical and physiological aspects. Sem Thromb Haemost 10:6-17, 1984

• 14) Rijken DC, et al:Measurement of human tissue-type plasminogen activatorb by two-site immunoradiometric assay. J Lab Clin Med 101:274:v 284, 1983

• 15) Bergsdorf N, et al:An enzyme linked immunosorbent assay for determination of tissue plasminogen activator applied to patients with thromboemboic disease. Thromb Haemost 50:740-744, 1983

• 16) Wiman B, et al:Plasminogen activator release during venous stasis andexercise as determined by a new specific assay. Clin Chim Acta 127:279-288, 1983

• 17) Matsuo O, et al:Determination of tissue plasminogen activator by an enzyme-immunoassay method. Anal Biochem 135:58-63, 1983
  pubmed

• 18) Geiger M, et al:Plasminogen activation in diabetes mellitus. J Biol Chem 259:2976-2981, 1984
  pubmed

VI. 凝固・線溶阻止因子の検査

P.231 掲載の参考文献

• 1) Odegard OR, et al:Heparin cofactor activitv measured with an amidolytic method. Thromb Res 6:287, 1975

• 2) Mancini G, et al:Immunochemical quantitation of antigens by single radial immunodiffusion. Internat J Immunochem 2:235-254, 1965

• 3) 向島達:Latex photometric immunoassay (LPIA) について. 臨床病理 31:254-261, 1983
  Medical*Online

• 4) 藤沢宗駿, 他:ラテックス凝集反応によるアンチトロンビンIIIの迅速測定法. 日血会誌 42:300, 1979

• 5) Biggs R:Antithrombin III, antifactor Xa and heparin cofactor. Brit J Haemat 19:283-306, 1970

P.236 掲載の参考文献

• 1) Teien AN and Lie:Evaluation of an amidolytic heparin assay method:increased sensitivity by adding purified antithrombin III. Thromb Res 10:399-410, 1977
  pubmed

• 2) Bartl K, et al:Determination of the biological activity of heparin by use of a chromogenic substrate. Thrombos Haemostas (Stuttg.) 22:1446-1451, 1979

P.244 掲載の参考文献

• 1) Naito K and Aoki N:Assay of a2-plasmin inhibitor activity by means of a plasmin specific tripeptide substrate. Thromb Res 12:1147, 1978

• 2) 藤巻道男, 他:血液凝固因子, 微生物検査必携. 免疫血清反応検査. 日本公衆衛生協会, 1978. p364

P.246 掲載の参考文献

• 1) 長沢洋:血液凝固因子に対する抗体. Medical Technology 13:761-764, 1985

P.250 掲載の参考文献

• 1) 福武勝博, 福武勝幸:阻止因子とバイパス療法. 日本臨牀 39:3688-3699, 1981
  Medical*Online

• 2) Kasper CK, et al:A more uniform measurment of factor VIII inhibitor. Thromb Diath Haemorrh 34:869-871, 1975

P.252 掲載の参考文献

• 1) 出口克己, 他:その他の循環抗凝血素. Medical Technology 13:769-771, 1985

• 2) Exner T and Richard KA:A sensitive test demonstrating lupus anticoagurant and its behavioural patterns. Brit J Haematol 40:143-151, 1978

P.265 掲載の参考文献

• 1) Mammen EF, et al:Activation of purified prothrombin to autoprothrombin I or autoprothrombin II (platelet cofactor III) or autoprothrombin II-A. Thromb Diath Haemorrh 5:218-249, 1960

• 2) Stenflo J:A new vitamin K-dependent protein. Purification from bovine plasma and preliminary characterizations. J Biol Chem 251:355-363, 1976
  pubmed

• 3) Kisiel W:Human plasma protein C:Isolation, characterization, and mechanism of activation by alpha-thrombin. J Clin Invest 64:761-769, 1979
  pubmed

• 4) Kisiel W:Proteolytic activation of protein C from bovine plasma. Biochemistry 15:4893-4900, 1976
  pubmed

• 5) Stocker K:Protein C activators in snake venoms. Behring Inst Mitt 79:37-47, 1986
  pubmed

• 6) Mannucci PM and Vigano S:Deficiencies of protein C, an inbibitor of blood coagulation. Lancet 2:463-466, 1982

• 7) Suzuki K, et al:Enzyme immunoassay of human protein C by using monoclonal antibodies. Thromb Res 38:611-621, 1985
  pubmed

• 8) Sala N, et al:A functional assay of protein C in human plasma. Blood 63:671 675, 1984

• 9) Bertina RM:The use of a functional and immunologic assay for plasma protein C in the study of the heterogeneity of congenital protein C deficiency. Thromb Haemostas 51:1-5, 1984

• 10) Francis RB and Patch MB:A functional assay for protein C in human plasma. Thromb Res 32:605-613, 1983

• 11) Francis RB and Patch MJ:A comparative study of commercial PTT reagents in a PTT-based functional protein C assay. Thromb Res 36:481-483, 1984

• 12) 楠本宏司, 他:蛇毒 Protac を用いた血漿プロテインCの生物活性測定法. 臨床病理 34 (補冊):54, 1986

• 13) 鈴木宏治:プロテインCおよびその関連物質, Medical Technology (臨時増刊) 13:756-761, 1985

• 14) Martinoli JL and Stocker K:Fast functional protein C assay using PROTAC, a novel protein C activator. Thromb Res 43:253-264, 1986
  pubmed

• 15) Soria J, et al:Severe protein C deficiency in congenital thrombotic disease-discription of an immunoenzymological assay for protein C determination. Thromb Haemstas 53:293-296, 1985

• 16) Tripodi A, et al:Comparison of a functional assay for protein C with two immunoassays. Thromb Res 40:243-248, 1985
  pubmed

• 17) Comp PC, et al:Determination of functional levels of protein C, an antithrombotic protein, using thrombin-thrombomodulin complex. Blood 63:15-21, 1984
  pubmed

• 18) Griffin JH, et al:Deficiency of protein C in congenital thrombotic disease. J Clin Invest 68:1370-1373, 1981

• 19) Broekmans AW, et al:Protein C and the development of skin necrosis during anticoagulant therapy. Thromb Haemostas 49:251, 1983

• 20) Vigano S, et al:Early fall of protein C during short-term anticoagulant therapy. Thromb Haemostas 50:310, 1983

VII. 凝固(線溶)亢進状態の検査

P.275 掲載の参考文献

• 1) Largo R, et al:Detection of soluble intermediates of the fibrinogen, fibrin conversion using erythrocytes coated with fibrin monomer. Blood 47:991, 1976

• 2) Lipinski B, et al:Detection of soluble test for fibrin monomer complex in blood by mealls of protamine sulfate test. Thromb Diath Haemorrh 20:44, 1968
  pubmed

• 3) Sanfelippo MJ, et al:Protamine sulfate test for fibrin monomer. Am J Clin Path 56:166, 1971

• 4) Niewiarowski S, et al:Laboratory identification of intravascular coagulation. J Lab Clin Med April:665, 1971

• 5) Breen FA, et al:Ethanol gelation:A rapid screening test for intravascular coagulation. Ann Int Med 69:1197, 1968
  pubmed

• 6) Godal HC, et al:Gelation of soluble fibrin in plasma by ethanol. Scand J Haemat 3:432, 1966

P.283 掲載の参考文献

• 1) Soria J, et al:A solid phase immunoenzymological assay for the measurement of human fibrinopeptide A. Thromb Res 20:425, 1980

• 2) Ohno Y, et al:Simple and sensitive radio immunoassay of fibrinopeptide BB15-42. Thromb Haemostas 50:953, 1983

P.287 掲載の参考文献

• 1) Ludlam CA, et al:The release of a human platelet specific protein measured by radioimmunoassay. Thromb Res 6:543-548, 1975
  pubmed

• 2) Kaplan KL and Owen J:Plasma levels of β-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood 57:199, 1981

P.292 掲載の参考文献

• 1) Ludlam CA, et al:The release of a human platelet-specific protein measured by radioimmunoassay. Thromb Res 6:543-548, 1975
  pubmed

• 2) Kaplan KL and Owen J:Plasma levels of B-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood 57:199, 1981

• 3) Weiss HJ, et al:Heterogeneity in storage pool deficiency; Studies on granulobound substance in 18 patients induced variants deficient in a-granules, platelet factor 4, B-thromboglobulin, and platelet-derived growth factor. Blood 54:1296-1319, 1979